MedPath

THAM

THAM SOLUTION Tromethamine Injection

Approved
Approval ID

4af52118-c12b-4ad5-30bb-959848357e8a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 18, 2023

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TROMETHAMINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-1593
Application NumberNDA013025
Product Classification
M
Marketing Category
C73594
G
Generic Name
TROMETHAMINE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 18, 2023
FDA Product Classification

INGREDIENTS (3)

TROMETHAMINEActive
Quantity: 3.6 g in 100 mL
Code: 023C2WHX2V
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

THAM - FDA Drug Approval Details